(HLN) Haleon - Performance 25.3% in 12m
HLN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
52.95%
#9 in Peer-Group
Rel. Strength
71.63%
#2188 in Stock-Universe
Total Return 12m
25.25%
#44 in Peer-Group
Total Return 5y
42.67%
#26 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 24.1 |
| P/E Forward | 20.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 11.41 USD |
| 52 Week Low | 8.19 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 4.11 |
| Buy/Sell Signal +-5 | 0.65 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: HLN (25.3%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: HLN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HLN
| Total Return (including Dividends) | HLN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -10.08% | 4.38% | 4.99% |
| 3 Months | 2.14% | 5.22% | 10.23% |
| 12 Months | 25.25% | -7.16% | 14.42% |
| 5 Years | 42.67% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | HLN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -93.7% | 3.5% | 79.1% |
| 3 Months | 58.3% | 75.7% | 95.5% |
| 12 Months | 57.4% | -85.1% | 44.7% |
| 5 Years | 90.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th20.50 | -13.85% | -14.35% |
| 3 Month | %th47.50 | -2.93% | -7.34% |
| 12 Month | %th78.50 | 34.91% | 9.46% |
| 5 Years | %th83.50 | 33.93% | -15.83% |
FAQs
Does Haleon (HLN) outperform the market?
Yes,
over the last 12 months HLN made 25.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months HLN made 2.14%, while XBI made 5.22%.
Performance Comparison HLN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HLN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.5% | -15.1% | 3.2% | 11% |
| US NASDAQ 100 | QQQ | -4.1% | -15.5% | 1.7% | 12% |
| German DAX 40 | DAX | -3.5% | -9.5% | -8.4% | -5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.8% | -14.2% | 2.7% | 8% |
| Hongkong Hang Seng | HSI | -2.5% | -17.2% | -15.4% | -11% |
| India NIFTY 50 | INDA | -3.4% | -12% | 5.8% | 26% |
| Brasil Bovespa | EWZ | -7.2% | -18.1% | -19.7% | 12% |
HLN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.4% | -15.8% | -1.1% | -1% |
| Consumer Discretionary | XLY | -5.6% | -13% | 10.1% | 6% |
| Consumer Staples | XLP | -4.8% | -10% | 3.7% | 15% |
| Energy | XLE | -5.1% | -16.2% | 8% | 27% |
| Financial | XLF | -4.6% | -13.7% | 0% | -3% |
| Health Care | XLV | -3.4% | -12.6% | 10.7% | 30% |
| Industrial | XLI | -5.3% | -14.3% | -3.6% | 1% |
| Materials | XLB | -7.6% | -15.9% | -1% | 18% |
| Real Estate | XLRE | -3.6% | -11% | 4.6% | 12% |
| Technology | XLK | -4% | -19.1% | 0.2% | 14% |
| Utilities | XLU | -3.2% | -9.6% | 1.9% | 2% |
| Aerospace & Defense | XAR | -4.7% | -17.6% | -15.2% | -23% |
| Biotech | XBI | -4.1% | -14.5% | 17.3% | 32% |
| Homebuilder | XHB | -9.4% | -21.7% | 9.2% | 19% |
| Retail | XRT | -7.1% | -15.6% | 8.4% | 15% |
HLN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.4% | -18.8% | 11.7% | 32% |
| Natural Gas | UNG | 0.4% | -1.5% | 19.3% | 31% |
| Gold | GLD | -3% | -9.3% | -16.1% | -18% |
| Silver | SLV | -3% | -15.3% | -13.5% | 2% |
| Copper | CPER | -6.8% | -16.2% | -17.4% | 8% |
HLN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.7% | -13.3% | 7.8% | 24% |
| iShares High Yield Corp. Bond | HYG | -3% | -12% | 5.1% | 15% |